HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuri Hamanaka Selected Research

Antigens

1/2018Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuri Hamanaka Research Topics

Disease

1Neoplasms (Cancer)
01/2018
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2012
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2012

Drug/Important Bio-Agent (IBA)

1AntigensIBA
01/2018

Therapy/Procedure

1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2012